{
    "startDate": "2022-01-01",
    "endDate": "2022-03-31",
    "year": "2022",
    "quarter": "Q1",
    "symbol": "ATAI",
    "data": {
        "bs": [
            {
                "label": "Other current liabilities",
                "concept": "OtherLiabilitiesCurrent",
                "unit": "usd",
                "value": 227000
            },
            {
                "label": "Other liabilities",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 4126000
            },
            {
                "label": "Total stockholders' equity",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 354357000
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 123975000
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 124000000.0
            },
            {
                "label": "Common stock, 0.10 par value ($0.12 par value at March 31, 2022 and December 31, 2021, respectively); 750,000,000 shares authorized at March 31, 2022 and December 31, 2021, respectively; 160,719,828 and 160,677,001 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 18007000
            },
            {
                "label": "Debt securities carried at fair value",
                "concept": "atai:DebtSecuritiesCarriedAtFairValue",
                "unit": "usd",
                "value": 210939000
            },
            {
                "label": "Accumulated other comprehensive income (loss)",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -12709000
            },
            {
                "label": "Noncontrolling interests",
                "concept": "MinorityInterest",
                "unit": "usd",
                "value": 8351000
            },
            {
                "label": "Noncontrolling interests",
                "concept": "MinorityInterest",
                "unit": "usd",
                "value": 8351000
            },
            {
                "label": "Equity Method Investments",
                "concept": "EquityMethodInvestments",
                "unit": "usd",
                "value": 9749000
            },
            {
                "label": "Equity Method Investments",
                "concept": "EquityMethodInvestments",
                "unit": "usd",
                "value": 9749000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 735380000
            },
            {
                "label": "Non-current portion of contingent consideration liability - related parties",
                "concept": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
                "unit": "usd",
                "value": 2433000
            },
            {
                "label": "Accrued liabilities",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 18252000
            },
            {
                "label": "Accrued liabilities",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 18252000
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 7504000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 3612000
            },
            {
                "label": "Commitments and contingencies (Note 15)",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Long term notes receivable - related parties",
                "concept": "NotesReceivableRelatedPartiesNoncurrent",
                "unit": "usd",
                "value": 6928000
            },
            {
                "label": "Total liabilities and stockholders' equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 383732000
            },
            {
                "label": "Total current assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 348786000
            },
            {
                "label": "Total assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 383732000
            },
            {
                "label": "Other investments",
                "concept": "OtherLongTermInvestments",
                "unit": "usd",
                "value": 10587000
            },
            {
                "label": "Other investments",
                "concept": "OtherLongTermInvestments",
                "unit": "usd",
                "value": 10587000
            },
            {
                "label": "Convertible promissory notes - related parties, net of discounts and deferred issuance costs",
                "concept": "ConvertibleLongTermNotesPayable",
                "unit": "usd",
                "value": 725000
            },
            {
                "label": "Short term notes receivable",
                "concept": "NotesAndLoansReceivableNetCurrent",
                "unit": "usd",
                "value": 887000
            },
            {
                "label": "Total stockholders' equity attributable to ATAI Life Sciences N.V. stockholders",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 346006000
            },
            {
                "label": "Total current liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 22091000
            },
            {
                "label": "Current portion of contingent consideration liability - related parties",
                "concept": "BusinessCombinationContingentConsiderationLiabilityCurrent",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 12985000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 12985000
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 178000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -394672000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -394700000.0
            },
            {
                "label": "Total liabilities",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 29375000
            }
        ],
        "cf": [
            {
                "label": "Cash paid for deferred offering costs",
                "concept": "PaymentsForRepurchaseOfInitialPublicOffering",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Deferred offering costs in accrued liabilities",
                "concept": "atai:DeferredOfferingCostsInAccruedLiabilities",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Net cash used in investing activities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -214736000
            },
            {
                "label": "Other",
                "concept": "PaymentsForProceedsFromOtherInvestingActivities",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Cash paid for tax withholdings related to stock options exercise",
                "concept": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Deferred revenue",
                "concept": "IncreaseDecreaseInDeferredRevenue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common stock issuance costs in accounts payable",
                "concept": "atai:CommonStockIssuanceCostsInAccountsPayable",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Net cash used in operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -23986000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": 1289000
            },
            {
                "label": "Amortization of debt discount",
                "concept": "AmortizationOfDebtDiscountPremium",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Change in fair value of derivative liability",
                "concept": "IncreaseDecreaseInDerivativeLiabilities",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Change in fair value of derivative liability",
                "concept": "IncreaseDecreaseInDerivativeLiabilities",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Proceeds from issuance of common stock",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Purchases of long - term notes receivable - related party",
                "concept": "OriginationOfNotesReceivableFromRelatedParties",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Issuance of derivative instrument related to convertible promissory notes",
                "concept": "atai:IssuanceOfDerivativeInstrumentRelatedToConvertiblePromissoryNotes",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Unbilled receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Proceeds from issuance of shares upon exercise of stock options",
                "concept": "ProceedsFromStockOptionsExercised",
                "unit": "usd",
                "value": 132000
            },
            {
                "label": "Cash paid for other investments",
                "concept": "PaymentsToAcquireOtherInvestments",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Purchases of short-term notes receivable",
                "concept": "PaymentsToAcquireNotesReceivable",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Deferred offering costs in accounts payable",
                "concept": "atai:DeferredOfferingCostsInAccountsPayable",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": -1886000
            },
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -37558000
            },
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -37558000
            },
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -37558000
            },
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -37558000
            },
            {
                "label": "Other",
                "concept": "OtherOperatingActivitiesCashFlowStatement",
                "unit": "usd",
                "value": -60000
            },
            {
                "label": "Stock-based compensation expense",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 10208000
            },
            {
                "label": "Loans to related parties",
                "concept": "PaymentsToFundLongtermLoansToRelatedParties",
                "unit": "usd",
                "value": 3000000
            },
            {
                "label": "Effect of foreign exchange rate changes on cash",
                "concept": "EffectOfExchangeRateOnCashAndCashEquivalents",
                "unit": "usd",
                "value": 299000
            },
            {
                "label": "Cash acquired in asset acquisitions, net",
                "concept": "CashAcquiredFromAcquisition",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Purchases of property and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 56000
            },
            {
                "label": "Common stock issuance costs in accrued liabilities",
                "concept": "atai:CommonStockIssuanceCostsInAccruedLiabilities",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Change in fair value of debt securities carried at fair value",
                "concept": "IncreaseDecreaseInDebtSecuritiesTrading",
                "unit": "usd",
                "value": -740000
            },
            {
                "label": "Change in fair value of debt securities carried at fair value",
                "concept": "IncreaseDecreaseInDebtSecuritiesTrading",
                "unit": "usd",
                "value": -740000
            },
            {
                "label": "Losses from investments in equity method investees",
                "concept": "atai:IncomeLossesFromEquityMethodInvestments",
                "unit": "usd",
                "value": 5596000
            },
            {
                "label": "Unrealized foreign exchange gains",
                "concept": "ForeignCurrencyTransactionGainLossUnrealized",
                "unit": "usd",
                "value": 1519000
            },
            {
                "label": "Net increase (decrease) in cash and cash equivalents",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": -238291000
            },
            {
                "label": "Cash paid for equity method investments",
                "concept": "PaymentsToAcquireEquityMethodInvestments",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Proceeds from secured borrowing liability",
                "concept": "ProceedsFromShortTermDebt",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Share subscriptions receivable",
                "concept": "atai:ShareSubscriptionsReceivable",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Fair value of noncontrolling interests issued in connection with asset acquisitions",
                "concept": "FairValueOfAssetsAcquired",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Right of use asset obtained in exchange for operating lease liabilities",
                "concept": "atai:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilities",
                "unit": "usd",
                "value": 245000
            },
            {
                "label": "Change in fair value of contingent consideration liability - related parties",
                "concept": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Change in fair value of contingent consideration liability - related parties",
                "concept": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Accrued liabilities",
                "concept": "IncreaseDecreaseInAccruedLiabilities",
                "unit": "usd",
                "value": 1722000
            },
            {
                "label": "In-process research and development expense",
                "concept": "ResearchAndDevelopmentInProcess",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Proceeds from issuance of share option awards",
                "concept": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Proceeds from issuance of convertible promissory notes",
                "concept": "ProceedsFromIssuanceOfDebt",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Cash paid for debt securities carried at fair value",
                "concept": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
                "unit": "usd",
                "value": 211680000
            },
            {
                "label": "Net cash provided by financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 132000
            },
            {
                "label": "Depreciation and amortization expense",
                "concept": "DepreciationDepletionAndAmortization",
                "unit": "usd",
                "value": 60000
            }
        ],
        "ic": [
            {
                "label": "Total operating expenses",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 33442000
            },
            {
                "label": "Foreign exchange gain (loss), net",
                "concept": "ForeignCurrencyTransactionGainLossBeforeTax",
                "unit": "usd",
                "value": 2163000
            },
            {
                "label": "Acquisition of in-process research and development",
                "concept": "atai:AcquisitionOfInProcessResearchAndDevelopment",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Change in fair value of debt securities carried at fair value",
                "concept": "IncreaseDecreaseInDebtSecuritiesTrading",
                "unit": "usd",
                "value": -740000
            },
            {
                "label": "Change in fair value of debt securities carried at fair value",
                "concept": "IncreaseDecreaseInDebtSecuritiesTrading",
                "unit": "usd",
                "value": -740000
            },
            {
                "label": "Interest income",
                "concept": "InvestmentIncomeInterest",
                "unit": "usd",
                "value": 98000
            },
            {
                "label": "Net income (loss) attributable to redeemable noncontrolling interests and noncontrolling interests",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -689000
            },
            {
                "label": "Net income (loss) attributable to redeemable noncontrolling interests and noncontrolling interests",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -689000
            },
            {
                "label": "Losses from investments in equity method investees, net of tax",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -5596000
            },
            {
                "label": "Provision for income taxes",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 41000
            },
            {
                "label": "Provision for income taxes",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 41000
            },
            {
                "label": "License revenue",
                "concept": "Revenues",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Income (loss) from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -33442000
            },
            {
                "label": "Net income (loss) per share attributable to ATAI Life Sciences N.V. stockholders - basic",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": -0.24
            },
            {
                "label": "Net income (loss) per share attributable to ATAI Life Sciences N.V. stockholders - basic",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": -0.24
            },
            {
                "label": "Weighted average common shares outstanding attributable to ATAI Life Sciences N.V. stockholders - diluted",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 153529268
            },
            {
                "label": "Weighted average common shares outstanding attributable to ATAI Life Sciences N.V. stockholders - diluted",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 153529268
            },
            {
                "label": "Weighted average common shares outstanding attributable to ATAI Life Sciences N.V. stockholders - basic",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 153529268
            },
            {
                "label": "Weighted average common shares outstanding attributable to ATAI Life Sciences N.V. stockholders - basic",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 153529268
            },
            {
                "label": "Change in fair value of derivative liability",
                "concept": "IncreaseDecreaseInDerivativeLiabilities",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Change in fair value of derivative liability",
                "concept": "IncreaseDecreaseInDerivativeLiabilities",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Net income (loss) per share attributable to ATAI Life Sciences N.V. stockholders - diluted",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": -0.24
            },
            {
                "label": "Net income (loss) per share attributable to ATAI Life Sciences N.V. stockholders - diluted",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": -0.24
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
                "unit": "usd",
                "value": 15460000
            },
            {
                "label": "Net income (loss) before income taxes",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -31921000
            },
            {
                "label": "Net loss attributable to ATAI Life Sciences N.V. stockholders",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -36869000
            },
            {
                "label": "Net loss attributable to ATAI Life Sciences N.V. stockholders",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -36869000
            },
            {
                "label": "Total other income (expense), net",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": 1521000
            },
            {
                "label": "Change in fair value of contingent consideration liability - related parties",
                "concept": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Change in fair value of contingent consideration liability - related parties",
                "concept": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 17982000
            },
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -37558000
            },
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -37558000
            },
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -37558000
            },
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -37558000
            },
            {
                "label": "Other income (expense), net",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Foreign currency translation adjustments, net of tax attributable to noncontrolling interests",
                "concept": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -11000
            },
            {
                "label": "Comprehensive income (loss) attributable to ATAI Life Sciences N.V. stockholders",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -41231000
            },
            {
                "label": "Comprehensive income (loss) attributable to redeemable noncontrolling interests and noncontrolling interests",
                "concept": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -700000
            },
            {
                "label": "Foreign currency translation adjustments, net of tax",
                "concept": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
                "unit": "usd",
                "value": -4373000
            },
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -37558000
            },
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -37558000
            },
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -37558000
            },
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -37558000
            },
            {
                "label": "Comprehensive income (loss)",
                "concept": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -41931000
            },
            {
                "label": "Comprehensive income (loss) attributable to redeemable noncontrolling interests and noncontrolling interests",
                "concept": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": -689000
            }
        ]
    }
}